Best Biopharma Outsourcing Companies in Zhejiang, China
The 45 best Biopharma Outsourcing companies in Zhejiang, China in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Innoforce Pharmaceuticals.
Our analysis of 100 Biopharma Outsourcing companies
$10.3b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Biopharma Outsourcing companies in Zhejiang
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | Innoforce Pharmaceuticals Manufacturer of biopharmaceuticals | $179M | 56 mo ago | Series A | Yuling Li Founder & CEO | 2018 | — | — |
| 2 | Hangzhou multi Jubilee Biotechnology Provider of drug research and development services | $155M | 63 mo ago | Series C | — | 2012 | — | — |
| 3 | Zhejiang Mingdu Zhikong Technology Provider of AI based logistics services | $73M | 29 mo ago | Series C | Wang Lijun CEO | 2017 | — | — |
| 4 | Nexchem Pharmaceutical Company engaged in manufacturing APIs | $45M | 184 mo ago | Acquired | — | 2002 | — | — |
| 5 | Hangzhou Changxi Provider of inhalation drug delivery platform services to pharma companies | $21M | 74 mo ago | Deadpooled | Huang Peng Co-founder & Vice President | 2014 | — | — |
| 6 | Chain Medical Labs Medical lab offering clinical lab testing, clinical trial and research services | $21M | 100 mo ago | Series B | Yao Guo CEO | 2012 | — | — |
| 7 | Pushikang Biological Technology R&D and consulting service company developing immunity, biochemical and, molecular diagnostic kits | $15M | 65 mo ago | Series C | — | 2014 | — | — |
| 8 | CarbonSilicon Provider of AI computing solutions for drug research & development services | $7M | 47 mo ago | Seed | Shi Hui Co-Founder | 2022 | — | — |
Top 12 Biopharma Outsourcing companies in Zhejiang
#1
Series C · Hangzhou, Zhejiang · founded 2017 · 500 employees$73.1Mraised▾
Provider of AI based logistics services
- Feb 2024Series C—
- May 2021Series B$47.1M
- Jul 2020Series A$11.4M
- Jul 2019Series A$14.5M
#2
Series A · Hangzhou, Zhejiang · founded 2018 · 2 employees$179Mraised▾
Manufacturer of biopharmaceuticals
- Dec 2021Series A$59M
- Mar 2021Series A$96M
- Jun 2020Seed$24M
#3
Series C · Hangzhou, Zhejiang · founded 2012 · 98 employees$155.4Mraised▾
Provider of drug research and development services
- May 2021Series C$155.4M
#4
Seed · Hangzhou, Zhejiang · founded 2022$7.2Mraised▾
Provider of AI computing solutions for drug research & development services
- Sep 2022Angel$7.2M
#5
Deadpooled · Hangzhou, Zhejiang · founded 2014$21.3Mraised▾
Hangzhou Changxi offers inhalation drug delivery platform services to pharma companies. The company has patented dry powder preparation technology and convenient inhaler technology. It helps its client in formulation development based on dry powder pulmonary delivery platform, technology transfer, and authorizes production.
- Jun 2020Series B$11.3M
- Jan 2018Series A$8.4M
- Apr 2016Seed$1.5M
#6
Series C · Shaoxing, Zhejiang · founded 2014 · 300 employees$15.5Mraised▾
Developer of microfluid analysis biotechnology designed for the chronic disease management detection field. The company focuses on In vitro diagnostic (IVD) reagents and clinical laboratory analysis instruments, enabling biomedical researchers to better analyze fluid samples.
- Feb 2021Series C$15.5M
- Apr 2020Series B—
#7
Acquired · Jinhua, Zhejiang · founded 2002 · 250 employees$44.6Mraised▾
Nexchem Pharmaceutical specialises in the research, production, and sales of Active Pharmaceutical Ingredients. Its current product portfolio has 7 APIs and 2 intermediates which include azithromycin dihydrate, clarithromycin, roxithromycin, fenofibrate, glimepiride, and benserazide hydrochloride.The company's research and development focus are on adding additional reaction capabilities and developing new API products. The company can manufacture products as per European and Japanese pharmacopoeia.
- Apr 2011Series A$27M
- Series B$17.6M
- Seed—
#8
Series B · Hangzhou, Zhejiang · founded 2012$20.9Mraised▾
Chain Medical Labs is primarily engaged in providing clinical testing services, drug clinical trial services, scientific research services, and also offers LIMS services to medical institutions. The company also assists clients in obtaining ISO15189 certification, CAP accreditation and also offers SOP process and external audit services. The company claims to be cooperating with scientific research institutions, and universities in areas such as R&D support and training of lab medicine professionals. The company has 3 labs for clinical, pathology and special lab testing applications.
- Apr 2018Series B—
- Nov 2016Series A$20.9M
- Jul 2015Series A—
#9
Series A · Hangzhou, Zhejiang · founded 2017—raised▾
Provider of clinical precision medication guidance services. The company focuses on building molecular platforms and mass spectrometry platforms to provide better and more reliable precision medicine solutions for global medical experts and patients.
- Feb 2024Series A—
- Apr 2022Seed—
#10
Seed · Hangzhou, Zhejiang · founded 2006 · 912 employees—raised▾
Drug research and development center
- Sep 2023Seed—
- Sep 2020Seed—
#11
Series B · Shaoxing, Zhejiang · founded 2012—raised▾
Zhejiang Meihua Ding Chang Pharmaceutical develops and manufactures finished formulations and biopeptides. They provide development services including generic product development, biopeptide development, cGMP drug analysis support, etc.
- Jul 2021Series B—
#12
Late Stage · Ningbo, Zhejiang · founded 1991—raised▾
Ningbo Zhengli Pharmaceutical Packaging manufactures pharmaceutical packaging products. The products of the company include pharmaceutical vial, pharmaceutical cartridges, pharmaceutical ampoules, pharmaceutical syringes, customized glass containers. The company has manufacturing facilities certified by ISO 9001 and FDA.
- 2018PE—
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Biopharma Outsourcing coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology in Zhejiang is moving
A read on the academic research around Biotechnology in Zhejiang — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 287 papers.
- Zhejiang University110
- ZheJiang Academy of Agricultural Sciences36
- Zhejiang A & F University26
- First Affiliated Hospital Zhejiang University21
- Zhejiang University of Technology18
- Gene1→12
- Transcription factor1→7
- Gene1→13
- Antibiotic resistance4
- Human health4
- Abiotic stress3
- Antibiotics3
- Biomanufacturing3
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.